HTG Molecular Diagnostics Inc (HTGMQ)
0.0025
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
HTG Molecular Diagnostics Cash from Financing (TTM): 1.729M for March 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2023 | 1.729M |
December 31, 2022 | 8.605M |
September 30, 2022 | 0.871M |
June 30, 2022 | 4.171M |
March 31, 2022 | 9.430M |
December 31, 2021 | 10.39M |
September 30, 2021 | 12.21M |
June 30, 2021 | 14.10M |
March 31, 2021 | 12.82M |
December 31, 2020 | 9.050M |
September 30, 2020 | 6.554M |
June 30, 2020 | 25.18M |
March 31, 2020 | 22.62M |
December 31, 2019 | 19.39M |
September 30, 2019 | 19.98M |
June 30, 2019 | -0.9287M |
March 31, 2019 | -1.128M |
Date | Value |
---|---|
December 31, 2018 | 38.13M |
September 30, 2018 | 42.49M |
June 30, 2018 | 42.84M |
March 31, 2018 | 56.28M |
December 31, 2017 | 15.75M |
September 30, 2017 | 11.75M |
June 30, 2017 | 9.911M |
March 31, 2017 | -4.686M |
December 31, 2016 | 2.026M |
September 30, 2016 | 1.796M |
June 30, 2016 | 3.482M |
March 31, 2016 | 53.37M |
December 31, 2015 | 51.11M |
September 30, 2015 | 50.04M |
June 30, 2015 | 58.82M |
March 31, 2015 | 10.20M |
December 31, 2014 | 15.65M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.9287M
Minimum
Jun 2019
25.18M
Maximum
Jun 2020
11.01M
Average
9.911M
Median
Cash from Financing (TTM) Benchmarks
Viveve Medical Inc | 0.069M |
Minerva Surgical Inc | 26.86M |
Stereotaxis Inc | 0.055M |
Electromed Inc | 0.149M |
Myomo Inc | 9.303M |